Healthcare provider profile · identity verified

Douglas R Newbold, MD

Family Practice · TAYLORSVILLE, UT · NPI 1447363239

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	681	199
Levothyroxine Sodium	Levothyroxine Sodium	387	96
Omeprazole	Omeprazole	265	79
Lisinopril	Lisinopril	245	69
Metformin Hcl Er	Metformin Hcl	244	74
Losartan Potassium	Losartan Potassium	224	74
Amlodipine Besylate	Amlodipine Besylate	208	60
Rosuvastatin Calcium	Rosuvastatin Calcium	157	48
Trazodone Hcl	Trazodone Hcl	149	42
Trulicity	Dulaglutide	136	25
Tamsulosin Hcl	Tamsulosin Hcl	133	35
Pantoprazole Sodium	Pantoprazole Sodium	120	40
Finasteride	Finasteride	119	32
Montelukast Sodium	Montelukast Sodium	117	32
Gabapentin	Gabapentin	111	33
Sertraline Hcl	Sertraline Hcl	102	31
Potassium Chloride	Potassium Chloride	100	32
Alendronate Sodium	Alendronate Sodium	98	32
Famotidine	Famotidine	98	27
Metformin Hcl	Metformin Hcl	97	27
Simvastatin	Simvastatin	95	28
Fluoxetine Hcl	Fluoxetine Hcl	93	24
Furosemide	Furosemide	91	31
Bupropion Xl	Bupropion Hcl	85	17
Duloxetine Hcl	Duloxetine Hcl	84	21
Ozempic	Semaglutide	84	13
Pravastatin Sodium	Pravastatin Sodium	80	27
Citalopram Hbr	Citalopram Hydrobromide	73	25
Metoprolol Succinate	Metoprolol Succinate	72	24
Jardiance	Empagliflozin	69	21
Albuterol Sulfate Hfa	Albuterol Sulfate	67	22
Mounjaro	Tirzepatide	66	14
Tizanidine Hcl	Tizanidine Hcl	65	23
Pregabalin	Pregabalin	62	22
Celecoxib	Celecoxib	61	19
Oxybutynin Chloride Er	Oxybutynin Chloride	56	14
Buspirone Hcl	Buspirone Hcl	54	14
Zolpidem Tartrate	Zolpidem Tartrate	54	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	15
Allopurinol	Allopurinol	49	17
Carvedilol	Carvedilol	47	16
Hydrochlorothiazide	Hydrochlorothiazide	46	16
Cephalexin	Cephalexin	43	27
Clonazepam	Clonazepam	43	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	16
Tramadol Hcl	Tramadol Hcl	42	14
Donepezil Hcl	Donepezil Hcl	40	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	40	30
Meloxicam	Meloxicam	38	12
Pioglitazone Hcl	Pioglitazone Hcl	38	11
Ezetimibe	Ezetimibe	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Methylprednisolone	Methylprednisolone	33	30
Nystatin	Nystatin	32	17
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Eliquis	Apixaban	31	11
Fluticasone Propionate	Fluticasone Propionate	31	19
Glimepiride	Glimepiride	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	11
Lamotrigine	Lamotrigine	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Estradiol	Estradiol	26	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Colesevelam Hcl	Colesevelam Hcl	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	20
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Temazepam	Temazepam	20	suppressed
Fluconazole	Fluconazole	19	12
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Ibuprofen	Ibuprofen	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Ramipril	Ramipril	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Prednisone	Prednisone	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Alogliptin	Alogliptin Benzoate	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error